Optimized Response-Adaptive Clinical Trials
Sequential Treatment Allocation Based on Markov Decision Problems
(Sprache: Englisch)
Two-armed response-adaptive clinical trials are modelled as Markov decision problems to pursue two overriding objectives: Firstly, to identify the superior treatment at the end of the trial and, secondly, to keep the number of patients receiving the...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
Fr. 59.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Optimized Response-Adaptive Clinical Trials “
Klappentext zu „Optimized Response-Adaptive Clinical Trials “
Two-armed response-adaptive clinical trials are modelled as Markov decision problems to pursue two overriding objectives: Firstly, to identify the superior treatment at the end of the trial and, secondly, to keep the number of patients receiving the inferior treatment small. Such clinical trial designs are very important, especially for rare diseases. Thomas Ondra presents the main solution techniques for Markov decision problems and provides a detailed description how to obtain optimal allocation sequences.
Inhaltsverzeichnis zu „Optimized Response-Adaptive Clinical Trials “
Introduction to Markov Decision Problems and Examples.- Finite and Infinite Horizon Markov Decision Problems.- Solution Algorithms: Backward Induction, Value Iteration and Policy Iteration.- Designing Response Adaptive Clinical Trials with Markov Decision Problems.
Autoren-Porträt von Thomas Ondra
Thomas Ondra obtained his Master of Science degree in mathematics at University of Vienna. He is a research assistant and PhD student at the Section for Medical Statistics of Medical University of Vienna.
Bibliographische Angaben
- Autor: Thomas Ondra
- 2014, 2015, XV, 102 Seiten, Masse: 14,8 x 21 cm, Kartoniert (TB), Englisch
- Verlag: Springer, Berlin
- ISBN-10: 3658083433
- ISBN-13: 9783658083434
- Erscheinungsdatum: 18.12.2014
Sprache:
Englisch
Pressezitat
"It is a remarkably concise exposition of the use of MDPs in a pharmaceutical setting; as such, the book's audience is the intersection of researchers and students with a sophisticated mathematical background and professionals in the pharmaceutical industry. ... the book is a very sophisticated treatise on MDP models for managing response-adaptive clinical trials and both mathematicians and pharmaceutical professionals would appreciate it." (James Smith, Interfaces, Vol. 45 (4), July-August, 2015)
Kommentar zu "Optimized Response-Adaptive Clinical Trials"
0 Gebrauchte Artikel zu „Optimized Response-Adaptive Clinical Trials“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Optimized Response-Adaptive Clinical Trials".
Kommentar verfassen